These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12829731)

  • 1. Treatment of adverse effects of excessive phencyclidine exposure in rats with a minimal dose of monoclonal antibody.
    Laurenzana EM; Gunnell MG; Gentry WB; Owens SM
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1092-8. PubMed ID: 12829731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-phencyclidine monoclonal antibody binding capacity is not the only determinant of effectiveness, disproving the concept that antibody capacity is easily surmounted.
    Pitas G; Laurenzana EM; Williams DK; Owens SM; Gentry WB
    Drug Metab Dispos; 2006 Jun; 34(6):906-12. PubMed ID: 16507651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics of a monoclonal antiphencyclidine Fab with broad selectivity for phencyclidine-like drugs.
    Hardin JS; Wessinger WD; Proksch JW; Owens SM
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1113-22. PubMed ID: 9618414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-phencyclidine monoclonal antibodies provide long-term reductions in brain phencyclidine concentrations during chronic phencyclidine administration in rats.
    Proksch JW; Gentry WB; Owens SM
    J Pharmacol Exp Ther; 2000 Mar; 292(3):831-7. PubMed ID: 10688594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single dose of monoclonal anti-phencyclidine IgG offers long-term reductions in phencyclidine behavioral effects in rats.
    Hardin JS; Wessinger WD; Wenger GR; Proksch JW; Laurenzana EM; Owens SM
    J Pharmacol Exp Ther; 2002 Jul; 302(1):119-26. PubMed ID: 12065708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphencyclidine monoclonal antibody therapy significantly changes phencyclidine concentrations in brain and other tissues in rats.
    Valentine JL; Owens SM
    J Pharmacol Exp Ther; 1996 Aug; 278(2):717-24. PubMed ID: 8768723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition of a monoclonal anti-phencyclidine Fab fragment of immunoglobulin G in rats.
    McClurkan MB; Valentine JL; Arnold L; Owens SM
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1439-45. PubMed ID: 8371148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-phencyclidine monoclonal Fab fragments markedly alter phencyclidine pharmacokinetics in rats.
    Valentine JL; Arnold LW; Owens SM
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1079-85. PubMed ID: 8014850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of locomotor sensitization induced by chronic phencyclidine administration.
    Phillips M; Wang C; Johnson KM
    J Pharmacol Exp Ther; 2001 Mar; 296(3):905-13. PubMed ID: 11181923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of rate of drug administration on the extent and time course of phencyclidine distribution in rat brain, testis, and serum.
    Proksch JW; Gentry WB; Owens SM
    Drug Metab Dispos; 2000 Jul; 28(7):742-7. PubMed ID: 10859146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiphencyclidine monoclonal Fab fragments reverse phencyclidine-induced behavioral effects and ataxia in rats.
    Valentine JL; Mayersohn M; Wessinger WD; Arnold LW; Owens SM
    J Pharmacol Exp Ther; 1996 Aug; 278(2):709-16. PubMed ID: 8768722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of gestational exposure to phencyclidine: distribution and neurochemical alterations in maternal and fetal brain.
    Ali SF; Ahmad G; Slikker W; Bondy SC
    Neurotoxicology; 1989; 10(3):383-92. PubMed ID: 2576301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of MS-153 on the development of behavioral sensitization to locomotion- and ataxia-inducing effects of phencyclidine.
    Abekawa T; Honda M; Ito K; Inoue T; Koyama T
    Psychopharmacology (Berl); 2002 Mar; 160(2):122-31. PubMed ID: 11875629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between intraperitoneal and subcutaneous phencyclidine administration in Sprague-Dawley rats: a locomotor activity and gene induction study.
    Kalinichev M; Robbins MJ; Hartfield EM; Maycox PR; Moore SH; Savage KM; Austin NE; Jones DN
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):414-22. PubMed ID: 17945407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat.
    Klamer D; Zhang J; Engel JA; Svensson L
    Behav Brain Res; 2005 Apr; 159(1):95-103. PubMed ID: 15795002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic mechanisms for obtaining high renal coelimination of phencyclidine and a monoclonal antiphencyclidine antigen-binding fragment of immunoglobulin G in the rat.
    Proksch JW; Gentry WB; Owens SM
    J Pharmacol Exp Ther; 1998 Nov; 287(2):616-24. PubMed ID: 9808688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated low dose of phencyclidine administration impairs spatial learning in mice: blockade by clozapine but not by haloperidol.
    Beraki S; Kuzmin A; Tai F; Ogren SO
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):486-97. PubMed ID: 18242064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficiency of an anti-(+)-methamphetamine monoclonal antibody in the protection against cardiovascular and central nervous system effects of (+)-methamphetamine in rats.
    Gentry WB; Laurenzana EM; Williams DK; West JR; Berg RJ; Terlea T; Owens SM
    Int Immunopharmacol; 2006 Jun; 6(6):968-77. PubMed ID: 16644483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal phencyclidine exposure alters hippocampal cell proliferation in offspring rats.
    Tanimura A; Liu J; Namba T; Seki T; Matsubara Y; Itoh M; Suzuki T; Arai H
    Synapse; 2009 Sep; 63(9):729-36. PubMed ID: 19425051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic anti-phencyclidine monoclonal antibody therapy decreases phencyclidine-induced in utero fetal mortality in pregnant rats.
    Hubbard JJ; Laurenzana EM; Williams DK; Gentry WB; Owens SM
    Int Immunopharmacol; 2011 Dec; 11(12):2181-7. PubMed ID: 22001428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.